News

The Department of Pediatrics is pleased to announce the appointment of Tiffany Schumaker, DO as Medical Director of the Pediatric Specialty Practice at Weill Cornell Medicine. In this role, Dr. Schumaker will work with the Vice Chair for Ambulatory Care Services ‐ Access and Strategy (ACSAS) and Departmental Leadership on overseeing clinical, educational, and operational activities of physicians, advanced practice providers, and pediatric residents and specialty fellows in the Pediatric Specialty Practice.

 Dr. Schumaker is an assistant professor of clinical pediatrics at Weill Cornell Medicine and an assistant attending pediatrician at NewYork-Presbyterian Komansky Children's Hospital. She received her medical degree from New York College of Osteopathic Medicine where she was also awarded membership to the Psi Sigma Alpha National Osteopathic Honor Society. She completed her residency in Pediatrics as Chief Resident at Cohen’s Children’s Medical Center, Long Island Jewish Hospital and her fellowship in Pediatric Endocrinology at NewYork-Presbyterian/Weill Cornell Medical Center. She is board certified in pediatrics and pediatric endocrinology.

The Department of Pediatrics is pleased to announce the promotion of Shipra Kaicker, MD to Associate Professor of Clinical Pediatrics, effective January 1, 2022.

 Dr. Shipra Kaicker earned her medical school degree (MBBS) from the University of Delhi, New Delhi India in 1991. She then completed her first pediatric residency at Maulana Azad Medical College, University of Delhi in 1995. This was followed by a second pediatric residency in the U.S at St. Vincent’s Medical Center, New York Medical College, New York. Dr. Kaicker completed her Pediatric Hematology Oncology fellowship from Columbia University College of Physicians and Surgeons in 2003. Upon completion of her fellowship, Dr. Kaicker joined the Maimonides Infant’s and Children’s Hospital in Brooklyn, New York as an attending physician and full-time faculty, where she mentored and trained numerous pediatric residents and medical students.

Congratulations to Adin Nelson, MD, MHPE, Assistant Professor of Clinical Pediatrics, on receiving the Department of Pediatrics 2022 Pilot Award for his study, What Can One Practice Question a Day Do For Pediatrics Residents?

Dr. Nelson’s project is a national prospective study that will examine how answering daily multiple-choice practice questions can improve residents’ learning. There is a growing body of literature on the strategy of studying with review questions - called retrieval practice, but it’s never been tested on a large scale in the real world. Dr. Nelson is partnering with the American Academy of Pediatrics and the Association of Pediatrics Program Directors to study this technique, making it one of the largest prospective studies ever done in medical education.

A team led by scientists at Weill Cornell Medicine, Scripps Research and the University of Chicago has identified an important site of vulnerability on influenza viruses—a site that future influenza vaccines and antibody therapies should be able to target to prevent or treat infections by a broad set of influenza strains.

The scientists, whose results are published Dec. 23 in Nature, found that a small subset of antibodies elicited by experimental and existing influenza vaccines target a site at the base, or anchor, of the influenza virus hemagglutinin (HA) protein—an “epitope” whose significance was not recognized in prior influenza antibody studies.

This article was originally posted on WCM Newsroom.

Following a sweeping effort in 2019 to address clinical care team well-being across Weill Cornell Medicine, physicians note a reduction in stress and feelings of burnout compared to previous surveys, according to a new report from the institution. 

The report, published online Nov. 17 and in the December issue of NEJM Catalyst Innovations in Care Delivery, suggests that Weill Cornell Medicine’s grassroots approach to improving physician wellness may be used as a model for other institutions grappling with health care provider burnout.

“Coming to work to do your best means you have to be at your best,” said Dr. Klaus Kjaer, chief quality and patient safety officer at Weill Cornell Medicine and the article’s lead author. “You need take care of yourself and your colleagues so that you can take care of your patients. We have realized that there has to be a strategy to create a workplace where our clinical care teams thrive, and we attract the best talent.”

Congratulations to Patrick Wilson, PhD, MS, Assistant Professor of Pediatrics (Interim), on being awarded a grant to develop a universal coronavirus vaccine as part of the PanCoVac - Pan-coronavirus Vaccine Consortium. The PanCoVac consortium brings together researchers from Weill Cornell Medicine, University of Wisconsin, and the University of Chicago to develop a vaccine candidate that provides universal protection from all coronavirus strains, including common coronavirus variants.

 As part of the consortium, Dr. Wilson and his team at Weill Cornell Medicine will analyze SARS-CoV-2 antibody responses and isolate human monoclonal antibodies (mAbs), from the B cells of COVID-19 patients, that bind to and protect against the virus. His team will also isolate antibodies that react to both SARS-CoV-2 and other coronavirus strains such as mutational variants, like the Delta variant, and now, Omicron, etc., and zoonotic coronaviruses that are a pandemic risk (i.e., other bat coronaviruses), as well as strains that cause common colds.

 Dr. Wilson will work in collaboration with Yoshi Kawaoka, PhD, of University of Wisconsin and Andrzej Joachimiac, PhD, Dsc, of University of Chicago to then characterize the isolated mAbs for activity against the various coronavirus strains to determine which can be used in designing a vaccine candidate.

The New York City-based RTW Charitable Foundation approved a grant of $55,000 to NewYork-Presbyterial Hospital/Weill Cornell Medical Center for a study entitled, “Pediatric mental health emergencies in an early epicenter of the COVID-19 pandemic: A multicentered study in NYC”. The study is part of a nationwide call for the pediatric medical community to address the ongoing children’s mental health crisis that has been exacerbated by the pandemic.

The study, led by investigators Cori Green, MD, Director of Behavioral Health Education and Integration in Pediatrics and Associate Professor of Clinical Pediatrics, Stephen Oh, MD, Assistant Professor of Surgery and Deborah Levine, MD, Associate Professor of Clinical Emergency Medicine and Pediatrics at Weill Cornell Medicine, will examine the pandemic’s impact on children’s mental health in comparison to a one-year period prior to the pandemic, as well as the rising trend in youth presenting with suicidal ideation (SI) and suicide attempt (SA). To do this, the team will use INSIGHT, the largest multicentered clinical data network in the nation, comprised of data from five major medical centers in New York City (NYC).

The Department of Pediatrics is pleased to announce the promotion of Thanakorn Jirasevijinda, MD to Professor of Teaching in Pediatrics.

Congratulations to Katherine A. Hajjar, MD, Vice Chair for Research and Brine Family Professor of Cell and Developmental Biology in the Department of Pediatrics at Weill Cornell Medicine, on being awarded a grant by the United States Department of Defense to develop treatment for proliferative vitreoretinopathy, a potentially blinding disease that occurs in almost one-half of military personnel who sustain a penetrating wound to the eye.

Proliferative vitreoretinopathy (PVR) occurs in some patients who have had complicated eye surgeries. When there is a tear in the retina, cells inside the eye, known as RPE cells, that normally remain behind the retina, begin to proliferate, move away from their normal position, and migrate to the inner surface of the retina. Over time, these migratory cells form a scar-like membrane that pulls the remaining retina away from the back of the eye, severely compromising vision. PVR is increasing in frequency among military personnel due to the increasing use of explosive devices in modern combat. Unfortunately, however, there is no treatment for this devastating disease.

Congratulations to Emily Wasserman, MD on receiving a $25,000 award from the HHV-6 Foundation for her project entitled, Association of Multi-system inflammatory syndrome in children and chromosomally integrated HHV6.

For this project, Dr. Wasserman and her team at Weill Cornell Medicine will determine the prevalence of chromosomally integrated human herpes virus 6 (ici‐HHV6) in a cohort of patients with multisystem inflammatory syndrome in children (MIS‐C).  HHV‐6 reactivation has been associated with hyperinflammatory states and a recent case report identified ici‐HHV6 in a patient with MIS‐C. Dr. Wasserman believes an association between ici‐HHV6 and MIS‐C would shed light on the pathogenesis of MIS‐C and hyperinflammatory responses to SARS-CoV2. 

Pediatrics Weill Cornell Medicine Appointments & Referrals: (646) 962-KIDS (646) 962-5437 Chair's Office: Weill Cornell Medicine 525 E 68th St.
Box 225
New York, NY 10065 (646) 962-5437